Viewing Study NCT02404558


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-03-11 @ 11:39 AM
Study NCT ID: NCT02404558
Status: COMPLETED
Last Update Posted: 2016-03-28
First Post: 2015-03-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid Arthritis
Sponsor: Sanofi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PDY14191
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View